Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Normal haemostasis and its regulation.

I J Mackie1, H A Bull

  • 1Haematology Department, Middlesex Hospital, London, UK.

Blood Reviews
|December 1, 1989
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Antibodies against TFPI and protein C are associated with a severe thrombotic phenotype in patients with and without antiphospholipid syndrome.

Thrombosis research·2018
Same author

A performance evaluation of a novel human recombinant tissue factor prothrombin time reagent (Revohem<sup>™</sup> PT).

International journal of laboratory hematology·2017
Same author

Rivaroxaban limits complement activation compared with warfarin in antiphospholipid syndrome patients with venous thromboembolism.

Journal of thrombosis and haemostasis : JTH·2016
Same author

Interactions between rivaroxaban and antiphospholipid antibodies in thrombotic antiphospholipid syndrome.

Journal of thrombosis and haemostasis : JTH·2015
Same author

Rivaroxaban and warfarin achieve effective anticoagulation, as assessed by inhibition of TG and in-vivo markers of coagulation activation, in patients with venous thromboembolism.

Thrombosis research·2015
Same author

Anti-protein C antibodies are associated with resistance to endogenous protein C activation and a severe thrombotic phenotype in antiphospholipid syndrome.

Journal of thrombosis and haemostasis : JTH·2014
Same journal

Treating large B-cell lymphoma: Current strategies and unmet needs across community and academic settings.

Blood reviews·2026
Same journal

MRD in multiple myeloma: Moving from "minimal" to "measurable".

Blood reviews·2026
Same journal

PRISMA-based systematic review on iron stores in repeat blood donors.

Blood reviews·2026
Same journal

Artificial intelligence applications in thrombotic thrombocytopenic Purpura: A systematic review of diagnostic, risk stratification, and prognostic models.

Blood reviews·2026
Same journal

Antibacterial, antifungal and antiviral prophylaxis and vaccination strategies in adult patients with acute myeloid and promyelocytic leukemia: An expert panel consensus from the GIMEMA group.

Blood reviews·2026
Same journal

The Lebanese national patient blood management guidelines: A new page in the medical practice.

Blood reviews·2026
See all related articles

Normal blood flow relies on balanced hemostasis, where endothelial cells limit thrombin generation. Disease states disrupt this balance, promoting clotting and inflammation.

Area of Science:

  • Vascular Biology
  • Hemostasis and Thrombosis
  • Cellular Signaling

Background:

  • Normal hemostasis and blood flow depend on intricate interactions between plasma proteins and blood cells.
  • The vascular endothelial cell plays a critical role in regulating hemostatic balance by limiting thrombin generation.
  • Endothelial cells synthesize anticoagulant molecules and regulate fibrinolysis, contributing to thromboresistance.

Purpose of the Study:

  • To elucidate the role of endothelial cells in maintaining hemostatic balance.
  • To understand how anticoagulant and fibrinolytic mechanisms are regulated.
  • To investigate the shift towards procoagulant mechanisms in disease states.

Main Methods:

  • Analysis of molecular interactions between plasma proteins, blood cells, and endothelial cells.

Related Experiment Videos

  • Investigation of endothelial cell synthesis and binding of regulatory molecules.
  • Examination of the effects of trauma, inflammation, and disease on hemostatic pathways.

    • Main Results:

    • Endothelial cells limit thrombin generation via localized anticoagulant processes.
    • Lipoxygenase and cyclo-oxygenase metabolites regulate endothelial thromboresistance.
    • Disease states trigger downregulation of anticoagulant/fibrinolytic pathways and upregulation of procoagulant mechanisms.

    Conclusions:

    • Endothelial cells are central to hemostatic regulation, synthesizing key anticoagulant and fibrinolytic factors.
    • Pro-inflammatory cytokines disrupt hemostatic balance by downregulating protective pathways and promoting thrombosis.
    • Understanding these mechanisms is crucial for addressing thrombotic disorders.